including ZMapp, Remdesivir, MAb114, REGN-EB3, in people with Ebola virus infection. The
study is expected to be complete by November 2024.
Anti-infective Drugs Market: Regional Analysis
On the basis of region, the global anti-infective drugs market is segmented into North America,
Latin America, Europe, Asia Pacific, Middle East, and Africa.
North America is expected to witness significant growth in the anti-infective drugs market over
the forecast period. This is owing increasing expansion activities by key players in this region.
For instance, in September 2018, Xellia Pharmaceuticals, a specialty pharmaceutical company
that offers anti-infective drugs against serious and often life-threatening infections, started its
new office in Buffalo Grove, near Chicago, Illinois to expand its sales and manufacturing
capabilities within the U.S.
Furthermore, Asia Pacific is expected to witness significant growth in the anti-infective drugs
market over the forecast period owing to new product launches in this region. For instance, in
September 2018, Astellas Pharma Inc. launched Dafclir Tablets 200 mg (fidaxomicin) for the
treatment of infectious enteritis (including pseudomembranous colitis) in Japan. Astelles has also
made an agreement with Merck in 2018 for development and marketing of Dafclir in Japan.
Report includes chapters which deeply display the following deliverable about industry :
• Anti-infective Drugs Market Research Objective and Assumption
• Anti-infective Drugs Market Purview - Report Description, Executive Summary, and Coherent
Opportunity Map (COM)
• Anti-infective Drugs Market Dynamics, Regulations, and Trends Analysis - Market Dynamics,
Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals,
Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Anti-infective Drugs Market, By Regions
• Anti-infective Drugs Market Competition by Manufacturers including Production, Share,
Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Anti-infective Drugs Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Anti-infective Drugs Market Manufacturing Cost Analysis including Key Raw Materials and Key
Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.